fda covid vaccine - Search News

News

FDA Restricts COVID-19 Vaccine Access To High-Risk Groups.

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.

· 9h

· 1h

FDA requires Covid vaccine makers to expand warnings

· 22h · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

FDA, COVID-19 pandemic

Digest more

FDA won’t approve COVID shot for healthy, non-elderly population

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

· 13h

· 2d · on MSN

FDA to limit covid shot approval to 65+, those with medical conditions

· 2d

New Trump vaccine policy limits access to COVID shots

1hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

6hon MSN

Changes are happening around COVID-19 vaccines: Here's what to know

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

4hon MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

Covid Vaccine Boosters Won’t Be Available for Healthy Adults Under 65. How Will That Work?

On May 20, U.S. Food and Drug Administration ( FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results